Australian Researchers Discover Placental Cells For Treating Lung Disorders
The Australian scientists have come up with a landmark finding that can help develop treatments for lung-related diseases, including emphysema, asbestosis and severe asthma. It has been discovered that with a type of cell found in human placentas, the inflammation and scarring in lungs can be treated.
The finding has been disclosed by a team from the Lung Institute of Western Australia and the Monash Institute of Medical Research. The team assures that they have tested the treatment on mice effectively, and are now intending to conduct trials on human tissue.
The findings were published in the American Journal of Respiratory and Critical Care Medicine.
Lead authors of the study, Associate Professor Yuben Moodley, shared that in the research it was found that some human placental cells, which originate from embryo, but are not part of the embryo, are then passed into the placenta where they form a part of it.
Moodley added that these cells have properties that can distinguish them from lung cells and this can possibly contribute in treating lung related problems as it did in the experimented mice.
Patients on ventilators, who develop inflammation from the ventilation and subsequent scarring, can be treated with the treatment cells, stated Moodley.
Also, patients suffering from disorders like emphysema, occupational lung disease asbestosis and severe asthma can also benefit from the discovered treatment.
New Zealand News
- Plug-in cars’ share grows to 32% in Netherlands in September 2021
- Italian motorcycle racer Valentino Rossi enters e-bike business with VR46 MTB range
- Micro Mobility shows off production version of Microlino 2.0 and 3-wheeled e-scooter
- Chinese electric motorcycle maker Evoke Motorcycles to set up shops in Spain